Literature DB >> 2439432

An immunohistochemical study of differentiation in malignant fibrous histiocytoma.

C W Lawson, C Fisher, K C Gatter.   

Abstract

Immunohistochemistry was used to examine 10 cases of malignant fibrous histiocytoma. Malignant cells in all cases expressed vimentin and in eight there was co-expression of either desmin or neurofilament, both of these being present in four cases. In addition, cytokeratin was found in one case. In each tumour, a population of small cells was identified which had the staining characteristics of benign macrophages, and this was distinct from the tumour cells. This study supports the concept that malignant fibrous histiocytoma is a tumour of mesenchymal cells rather than of histiocytes and emphasizes the diversity of its cytostructure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439432     DOI: 10.1111/j.1365-2559.1987.tb02642.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  22 in total

Review 1.  Malignant fibrous histiocytoma: past, present, and future.

Authors:  A E Rosenberg
Journal:  Skeletal Radiol       Date:  2003-09-27       Impact factor: 2.199

2.  Inflammatory pseudotumor of lymph nodes. Immunohistochemical evidence for its fibrohistiocytic nature.

Authors:  F Facchetti; C De Wolf Peeters; I De Wever; G Frizzera
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

3.  Biological characterization of human bone tumors. X. The proliferation behavior of macrophages as compared to fibroblastic cells in malignant fibrous histiocytoma and giant cell tumor of bone.

Authors:  A Roessner; J Vassallo; E Vollmer; G Zwadlo; C Sorg; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Towards the phenotyping of soft tissue tumours by cell surface molecules.

Authors:  G Mechtersheimer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

5.  Cytoskeletal characteristics of myofibroblasts in benign neoplastic and reactive fibroblastic lesions.

Authors:  T Hasegawa; T Hirose; E Kudo; J Abe; K Hizawa
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

6.  Malignant fibrous histiocytoma.

Authors:  J R Salisbury
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

7.  Desmin: its value as a marker of muscle derived tumours using a commercial antibody.

Authors:  M Leader; M Collins; J Patel; K Henry
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

8.  FU-3 monoclonal antibody: a specific marker for malignant fibrous histiocytoma? An analysis of 32 malignant soft tissue and bone sarcomas.

Authors:  M J Perez-Bacete; A Llombart-Bosch
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Transformation potential of bone marrow stromal cells into undifferentiated high-grade pleomorphic sarcoma.

Authors:  Qing Li; Hiroko Hisha; Takashi Takaki; Yasushi Adachi; Ming Li; Changye Song; Wei Feng; Satoshi Okazaki; Tomomi Mizokami; Junko Kato; Muneo Inaba; Naoki Hosaka; Masahiko Maki; Susumu Ikehara
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-21       Impact factor: 4.553

10.  Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation.

Authors:  G Tallini; D M Parham; P Dias; C Cordon-Cardo; P J Houghton; J Rosai
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.